PURPOSE OF REVIEW: The principal aim of this review is to highlight recent advances in our understanding of cognitive dysfunction in major depressive disorder (MDD). We review new assessment and treatment approaches, in which cognition and associated psychosocial dysfunction are considered primary outcomes. RECENT FINDINGS: Current work suggests that cognitive dysfunction reduces occupational productivity, and interferes broadly with domains of day-to-day and social functioning. These findings imply that cognitive dysfunction interacts with emotional and social factors relevant to MDD. Recent advances in screening instruments enable standardized detection of cognitive symptoms in MDD. Clinical trials suggest that cognitive symptoms are suitable targets and primary outcomes of psychological and pharmacological treatments. SUMMARY: A growing interest in cognitive dysfunction in MDD has improved our ability to assess and treat MDD. Future research will be strengthened by the use of consistent terminology, standardized cognitive screening, and treatments that target cognitive dysfunction in MDD. Integration of emotional and social treatment strategies may further advance clinical efficacy.
PURPOSE OF REVIEW: The principal aim of this review is to highlight recent advances in our understanding of cognitive dysfunction in major depressive disorder (MDD). We review new assessment and treatment approaches, in which cognition and associated psychosocial dysfunction are considered primary outcomes. RECENT FINDINGS: Current work suggests that cognitive dysfunction reduces occupational productivity, and interferes broadly with domains of day-to-day and social functioning. These findings imply that cognitive dysfunction interacts with emotional and social factors relevant to MDD. Recent advances in screening instruments enable standardized detection of cognitive symptoms in MDD. Clinical trials suggest that cognitive symptoms are suitable targets and primary outcomes of psychological and pharmacological treatments. SUMMARY: A growing interest in cognitive dysfunction in MDD has improved our ability to assess and treat MDD. Future research will be strengthened by the use of consistent terminology, standardized cognitive screening, and treatments that target cognitive dysfunction in MDD. Integration of emotional and social treatment strategies may further advance clinical efficacy.
Authors: Ann D Cohen; Yichen Jia; Stephen Smagula; Chung-Chou H Chang; Beth Snitz; Sarah B Berman; Erin Jacobsen; Mary Ganguli Journal: J Gerontol A Biol Sci Med Sci Date: 2021-02-25 Impact factor: 6.053
Authors: Tamsyn E Van Rheenen; Kathryn E Lewandowski; Jessica M Lipschitz; Katherine E Burdick Journal: CNS Spectr Date: 2018-09-24 Impact factor: 3.790
Authors: Susanne Meinert; Nico Nowack; Dominik Grotegerd; Jonathan Repple; Nils R Winter; Isabel Abheiden; Verena Enneking; Hannah Lemke; Lena Waltemate; Frederike Stein; Katharina Brosch; Simon Schmitt; Tina Meller; Julia-Katharina Pfarr; Kai Ringwald; Olaf Steinsträter; Marius Gruber; Igor Nenadić; Axel Krug; Elisabeth J Leehr; Tim Hahn; Katharina Thiel; Katharina Dohm; Alexandra Winter; Nils Opel; Ricarda I Schubotz; Tilo Kircher; Udo Dannlowski Journal: Mol Psychiatry Date: 2021-10-25 Impact factor: 13.437
Authors: Eve Cosker; Marie Moulard; Samuel Schmitt; Karine Angioi-Duprez; Cédric Baumann; Vincent Laprévote; Raymund Schwan; Thomas Schwitzer Journal: BMJ Open Date: 2021-07-09 Impact factor: 2.692